On this episode of the SCR Podcast we are hosting Jeroen Tas who has a rermarkable career both as an entrepreneur scaling his company to $1+ billion in revenues, which got acquired by HP and being a senior executive as the former Chief Innovation Officer of Royal Philips.

Together with Jeroen we are starting the epsiode with discussing the critical skill of identifying windows of opportunities as an entrepreneur. Jeroen also shares his opinion on why he believes  that early stage startups should be careful when choosing "random" revenue rather than focusing on developing a robust and visionary product.

On this episode of the SCR Podcast we are hosting Alex Louisy who is the Co-Founder and CEO of Upflow (YCW20). 

Together with Alex we start-off by discussing all things that a second-time founder does different. Alex is sharing his experience of starting a company in France, getting into YC and pivoting the business by tackling the US market. Beyond that we also touch upon Stripe's concept of macro optimism/micro pessimism and exchange on the factual meaning of VC-Founder partnerships. 

On this epsiode we are honored to host Phil Libin who is a serial entrepreneur. Among the companies he co-founded are Evernote, All Turtles and mmhmm. He is an expert in building great products with hundreds of millions of users.

Together we are getting Phil's opinion on building winning products that solve real problems and what it means to being a great product person. Phil also shares his opinion on why being opinionated in the early stages of building a product is far more important than talking to customers. 

Tune in and subscribe to the SPEED CHANGE REPEAT Podcast for a weekly episode. 

On this epsiode we are hosting Matt Brown who is a Partner at the early stage VC firm Matrix, based in San-Francisco and Boston. 

Matt previously founded Bonsai and Work4 and led merchant product at Afterpay. 

Together we are diving into the art of balancing early stage product building and the ever increasing importance of distribution and challenges around platform dependencies. We are also covering a new defining category of SaaS products, which Matt labels as VERPs: Vertical ERPS. 

Tune in and subscribe to the SPEED CHANGE REPEAT Podcast for a weekly epsiode! 

On this epsiode we are hosting the Lucy Jung who is the Co-Founder and CEO of Charco Neurotech, a company that developed a non-invasive wearable device for Parkinson's disease. 

Together with Lucy we dive into the ins-and-outs of product design and development for hardware and medical products. Lucy gives an insight into her fundraising experiences and what it means to develop a global distribution system as a start-up. 

For the first epsiode of the year we are starting with a little 2022 reflection on the podcast and the take aways for the upcoming year of hosting the show. 

The SPEED CHANGE REPEAT Podcast is going to be a place where some of the worlds most incredible founders and operators will share their learnings and experiences from building tech companies. 

We are starting-off the year strong with upcoming conversations, hosting Phil Libin (Co-Founder of Evernote) and Jeffrey Kaditz (Co-Founder of Affirm) 

Dr. BJ Fogg is a behavior scientist and Adjunct Professor at Stanford University where he founded the Behavior Design Lab. 

BJ is an expert on behavior change for health habits and author of the book "Tiny Habits", which is a New York Times Bestseller. 

Among many of the interesting topics in this episode we are diving into the details of changing behavior towards improving human health and discuss the challenges of the healthtech start-up ecosystem targeting behavior change as a feature. 

We are also touching BJ's new area of interest, which is tackling the science behind bad habits and approaches of tackling them. 

On this episode of the SPEED CHANGE REPEAT Podcast we are talking with Florian Brand who is CEO and Co-Founder at ATAI Life Sciences. 

The company is aiming to develop differentiated treatments for patients suffering from mental health orders.

Having collected over $500m in capital with noteable backing from investors such as Cathie Wood at ARK Invest, ATAI is at the forefront when it comes to the psychedelics market. 

Together with Florian we are covering the early founding of the company and dive deep into the company's funding model for compound development as well as the role of digital therapeutics in ATAI's treatment strategy. 

On this epsiode we are hosting Tero-Pekka Alastalo.

Tero and his team founded BluePrint Genetics a Stanford University spin off that has been focusing on developing innovative technologies for rare disease genetic diagnostics. The company was acquired by Quest Diagnostics in 2020. 

Together we are talking about the early stages of building Blueprint Genetics and the aspects of expanding companies in the US market. 

We also cover venture opportunities for heart health and talk about CardioSignal, which is developing a disruptive mobile application-based technology to improve the detection of heart disease.

On this episode we are hosting Jason Moore who is the CEO of Spren a company focused on providing insights into human biology through its digital biomarker platform. 

Jason and his team have been operating a profitable business for years before deciding to take a turn and take on venture capital to execute on a bigger vision. The company now provides biometric data through its SDK to other players in the health and wellness space. 

We are talking about their bootstrapping journey and the different product development stages before they took on external funding as well as the product roadmap for the company in the overall digital health vertical.